On March 7, 2023, Carisma Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | 0.00% | +0.61% | -44.03% |
Apr. 11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Apr. 02 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
38.98 CNY | -1.32% | +2.99% | 4.34B | ||
1.64 USD | 0.00% | +0.61% | 68.13M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.03% | 68.13M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Carisma Therapeutics, Inc. announced that it has received $30 million in funding from a group of investors